Politician trade (House)

Eli Lilly (LLY)Rep. Michael Rulli (OH06) disclosed a purchase $1K–$15K

Rep. Michael Rulli (OH06) disclosed a purchase of Eli Lilly in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount: 217 days
Disclosure lag

Traded: Jan 2, 2026
Disclosed: Aug 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 24, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
Oct 31, 2025Insider · 1 personInsiders: 8 sales (~$260.2M)
Nov 3, 2025Insider · 1 personInsiders: 24 sales (~$266.6M)
Nov 4, 2025Insider10% owner sold ~$479K of LLY shares in the open market
Nov 5, 2025Insider · 1 personInsiders: 38 sales (~$205.6M)
Nov 10, 2025Insider · 1 personInsiders: 2 sales (~$16.3M)
Nov 11, 2025Insider · 1 personInsiders: 6 sales (~$66.5M)
Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, the Board of Directors (the “Board”) of Eli Lilly and Company (the “Company”) elected Carolyn R. Bertozzi, Ph.D as a new member of the Board, effective December 8, 2025.”
Nov 20, 2025FDAFDA drug approval: Retevmo
Nov 20, 2025FDAFDA drug approval: Retevmo
Dec 19, 2025FDAFDA drug approval: Mounjaro

What came next

Jan 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.8%
Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
Apr 1, 2026FDAFDA drug approval: Foundayo
Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%

View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Rep. Michael Rulli (OH06)

The full history of Rep. Michael Rulli (OH06) is on the profile page.

How this filing works

The STOCK Act

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data